91Â鶹ÌìÃÀ Applauds Congress for Supporting Science in FY26 Funding
Key Points
- 91Â鶹ÌìÃÀ commends Congress for passing a fiscal year (FY) 2026 funding package that reaffirms the federal government’s commitment to science, public health and preparedness.
- 91Â鶹ÌìÃÀ now urges the Trump Administration to move swiftly in distributing FY2026 appropriated funds as Congress intended so that researchers, laboratories and public health professionals can put these resources to work without delay.
The American Society for Microbiology (91Â鶹ÌìÃÀ) commends Congress for passing a fiscal year (FY) 2026 funding package that reaffirms the federal government’s commitment to science, public health and preparedness. We are encouraged to see sustained investment across multiple agencies that fund microbial research and innovation. At a time when scientific research and public health programs face significant uncertainty, congressional leadership has been essential to sustaining the nation’s research enterprise and protecting public health.
91Â鶹ÌìÃÀ strongly supports Congress’ decision to invest in the microbial sciences. We are especially encouraged by Congress providing the first funding increase since FY2023 for the CDC’s Advanced Molecular Detection program, an essential public health tool providing genomic sequencing to quickly detect and respond to infectious diseases.
91Â鶹ÌìÃÀ now urges the Trump Administration to move swiftly in distributing FY2026 appropriated funds as Congress intended so that researchers, laboratories and public health professionals can put these resources to work without delay. Looking ahead, we encourage Congress to build on this momentum by delivering robust funding in FY2027 for federal science agencies including the National Institutes of Health, the Centers for Disease Control and Prevention, the National Science Foundation, the Department of Energy Office of Science, the Department of Agriculture and others.
91Â鶹ÌìÃÀ and our more than 38,000 members look forward to working with House and Senate leaders and the Administration in the coming months to ensure that science and public health remain national priorities.
91Â鶹ÌìÃÀ strongly supports Congress’ decision to invest in the microbial sciences. We are especially encouraged by Congress providing the first funding increase since FY2023 for the CDC’s Advanced Molecular Detection program, an essential public health tool providing genomic sequencing to quickly detect and respond to infectious diseases.
91Â鶹ÌìÃÀ now urges the Trump Administration to move swiftly in distributing FY2026 appropriated funds as Congress intended so that researchers, laboratories and public health professionals can put these resources to work without delay. Looking ahead, we encourage Congress to build on this momentum by delivering robust funding in FY2027 for federal science agencies including the National Institutes of Health, the Centers for Disease Control and Prevention, the National Science Foundation, the Department of Energy Office of Science, the Department of Agriculture and others.
91Â鶹ÌìÃÀ and our more than 38,000 members look forward to working with House and Senate leaders and the Administration in the coming months to ensure that science and public health remain national priorities.